Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Eye (London, England)|January 12, 2022
Review of gene therapies for age-related macular degenerationArshad M Khanani, Mathew J Thomas, Aamir A Aziz, et al.
Eclinicalmedicine|December 28, 2023
Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 studyArshad M Khanani, David S Boyer, Charles C Wykoff, et al.
Ophthalmology. Retina|May 8, 2024
Vision Loss Reduction with Avacincaptad Pegol for Geographic Atrophy: A 12-Month Post Hoc Analysis of the GATHER1 and GATHER2 TrialsCarl J Danzig, Arshad M Khanani, Peter K Kaiser, et al.
Ophthalmology Science|October 9, 2023
BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion: Study Design and RationaleLars-Olof Hattenbach, Francis Abreu, Pablo Arrisi, et al.
Ophthalmology. Retina|March 19, 2025
Faricimab Treat-and-Extend Dosing for Macular Edema Due to Retinal Vein Occlusion: 72-Week Results from the BALATON and COMINO TrialsCarl J Danzig, Christiana Dinah, Faruque Ghanchi, et al.
Ophthalmology|December 17, 2025
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 2-year efficacy and safety results from the GATHER2 phase 3 trialArshad M Khanani, Carl J Danzig, Jeffrey S Heier, et al.
Ophthalmology|January 27, 2024
Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion: 24-Week Results from the BALATON and COMINO TrialsRamin Tadayoni, Liliana P Paris, Carl J Danzig, et al.
Lancet (London, England)|September 11, 2023
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trialArshad M Khanani, Sunil S Patel, Giovanni Staurenghi, et al.
Eye (London, England)|May 12, 2023
The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study - 6 month resultsArshad M Khanani, Aamir A Aziz, Hannah Khan, et al.
Pageof 2